List of Oncolytics Biotech patents

Patents where

Current Assignee

Name

Oncolytics Biotech

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7163678 Reovirus for the treatment of ral-mediated cellular proliferative disorders	Patent 7163678 was granted and assigned to Oncolytics Biotech on January, 2007 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	7163678	January 16, 2007
‌ US Patent 7374752 Reovirus for the treatment of cellular proliferative disorders	Patent 7374752 was granted and assigned to Oncolytics Biotech on May, 2008 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	7374752	May 20, 2008
‌ US Patent 7300650 Reovirus for the treatment of neoplasia	Patent 7300650 was granted and assigned to Oncolytics Biotech on November, 2007 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	7300650	November 27, 2007
‌ US Patent 7901921 Viral purification methods	Patent 7901921 was granted and assigned to Oncolytics Biotech on March, 2011 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	7901921	March 8, 2011
‌ US Patent 7476382 Reovirus for the treatment of neoplasia	Patent 7476382 was granted and assigned to Oncolytics Biotech on January, 2009 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	7476382	January 13, 2009
‌ US Patent 7252817 Viruses for the treatment of cellular proliferative disorders	Patent 7252817 was granted and assigned to Oncolytics Biotech on August, 2007 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	7252817	August 7, 2007
‌ US Patent 7223585 Viral purification methods	Patent 7223585 was granted and assigned to Oncolytics Biotech on May, 2007 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	7223585	May 29, 2007
‌ US Patent 9045728 Liquid viral formulations	Patent 9045728 was granted and assigned to Oncolytics Biotech on June, 2015 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	9045728	June 2, 2015
‌ US Patent 7264798 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus	Patent 7264798 was granted and assigned to Oncolytics Biotech on September, 2007 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	7264798	September 4, 2007
‌ US Patent 7344711 Use of adenoviruses mutated in the VA genes for cancer treatment	Patent 7344711 was granted and assigned to Oncolytics Biotech on March, 2008 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	7344711	March 18, 2008
‌ US Patent 7429485 Method of producing infectious reovirus	Patent 7429485 was granted and assigned to Oncolytics Biotech on September, 2008 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	7429485	September 30, 2008
‌ US Patent 9610352 Lyophilized viral formulations	Patent 9610352 was granted and assigned to Oncolytics Biotech on April, 2017 by the United States Patent and Trademark Office.	Oncolytics Biotech	Oncolytics Biotech	United States Patent and Trademark Office	9610352	April 4, 2017
‌ US Patent 11246930 Reoviruses having modified sequences	Patent 11246930 was granted and assigned to Oncolytics Biotech on February, 2022 by the United States Patent and Trademark Office.	Oncolytics Biotech	Oncolytics Biotech	United States Patent and Trademark Office	11246930	February 15, 2022
‌ US Patent 7727534 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions	Patent 7727534 was granted and assigned to Oncolytics Biotech on June, 2010 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	7727534	June 1, 2010
‌ US Patent 9044498 Lyophilized viral formulations	Patent 9044498 was granted and assigned to Oncolytics Biotech on June, 2015 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	9044498	June 2, 2015
‌ US Patent 7799329 Viruses for the treatment of cellular proliferative disorders	Patent 7799329 was granted and assigned to Oncolytics Biotech on September, 2010 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	7799329	September 21, 2010
‌ US Patent 7708987 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders	Patent 7708987 was granted and assigned to Oncolytics Biotech on May, 2010 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	7708987	May 4, 2010
‌ US Patent 8658158 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus	Patent 8658158 was granted and assigned to Oncolytics Biotech on February, 2014 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	8658158	February 25, 2014
‌ US Patent 8071087 Reovirus for the treatment of cellular proliferative disorders	Patent 8071087 was granted and assigned to Oncolytics Biotech on December, 2011 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	8071087	December 6, 2011
‌ US Patent 8491886 Viruses for the treatment of cellular proliferative disorders	Patent 8491886 was granted and assigned to Oncolytics Biotech on July, 2013 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	8491886	July 23, 2013
‌ US Patent 7803385 Reoviruses having modified sequences	Patent 7803385 was granted and assigned to Oncolytics Biotech on September, 2010 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	7803385	September 28, 2010
‌ US Patent 7964187 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus	Patent 7964187 was granted and assigned to Oncolytics Biotech on June, 2011 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	7964187	June 21, 2011
‌ US Patent 9365823 Virus clearance of neoplastic cells from mixed cellular compositions	Patent 9365823 was granted and assigned to Oncolytics Biotech on June, 2016 by the United States Patent and Trademark Office.	Oncolytics Biotech	Oncolytics Biotech	United States Patent and Trademark Office	9365823	June 14, 2016
‌ US Patent 9610309 Liquid viral formulations	Patent 9610309 was granted and assigned to Oncolytics Biotech on April, 2017 by the United States Patent and Trademark Office.	Oncolytics Biotech	Oncolytics Biotech	United States Patent and Trademark Office	9610309	April 4, 2017
‌ US Patent 7198783 Sensitization of neoplastic cells to radiation therapy with reovirus	Patent 7198783 was granted and assigned to Oncolytics Biotech on April, 2007 by the United States Patent and Trademark Office.		Oncolytics Biotech	United States Patent and Trademark Office	7198783	April 3, 2007

Results per page:

47 results

0 selected

47 results

0 selected